Fluo Labs: The Future of Allergy Relief (212)

Episode 12 May 14, 2022 00:25:00
Fluo Labs: The Future of Allergy Relief (212)
Innovation4Alpha
Fluo Labs: The Future of Allergy Relief (212)

May 14 2022 | 00:25:00

/

Show Notes

Fluo Labs, Inc. is a premarket clinical stage medical device company pursuing innovative technology to provide drug-free relief of nasal allergy (i.e. hay fever) symptoms. They are inventing a whole new way for sufferers of seasonal allergies to get symptom relief, and ultimately improve their quality of life. The Fluo device is designed to use light therapy to reduce inflammation and temporarily alleviate allergy symptoms as a completely drug-free alternative to common allergy medications.

Other Episodes

Episode 17

August 25, 2021 00:30:35
Episode Cover

Startup Profile: Elims (017)

Elims is a social impact company that combines seriously effective oral care + real sustainability. They believe you don't have to compromise your health...

Listen

Episode 23

June 11, 2022 00:41:34
Episode Cover

From Ukraine to Uganda - Project Cure Delivers Critical Medical Equipment and Supplies (223)

Project Cure CEO Douglas Jackson, PhD shares the mission of Project Cure in a wide ranging discussion that illustrates the incredible supply chain expertise...

Listen

Episode 229

August 21, 2022 00:13:52
Episode Cover

Mark Cherney: Founder, US Urology Partners - The State of Private Equity (229)

Mark Cherney is the Founder and Executive Chairman of both US Urology Partners and Prologics. This past year Mark transitioned from the CEO role...

Listen